ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,193Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 337

$1.51M Total Retail Price of All Prescriptions

Rank: 5 out of 337

693 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 693 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 693 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 25,603 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 1,414 1,257 1 11
FUROSEMIDE 1,176 1,079 2 8
TRAZODONE HCL 1,098 988 3 16
LEVOTHYROXINE SODIUM 954 891 4 5
SIMVASTATIN 931 819 5 1
AMLODIPINE BESYLATE 825 770 6 3
METOPROLOL TARTRATE 796 738 7 6
MIRTAZAPINE 723 712 8 27
LISINOPRIL 671 551 9 2
CITALOPRAM HBR 550 507 10 17
OMEPRAZOLE 546 431 11 4
GABAPENTIN 546 458 11 20
DONEPEZIL HCL 457 457 13 22
SERTRALINE HCL 454 429 14 18
POLYETHYLENE GLYCOL 3350 369 339 15 47
ATENOLOL 358 319 16 10
POTASSIUM CHLORIDE 330 300 17 62
NAMENDA 302 288 18 35
CYMBALTA 288 205 19 59
ATORVASTATIN CALCIUM 286 248 20 7
SPIRIVA 284 246 21 43
HYDROCODONE-ACETAMINOPHEN 272 195 S3 22 13
LIDODERM 256 242 23 82
RANITIDINE HCL 253 237 24 30
OXYCODONE HCL 252 222 S2 25 63
HYDROCHLOROTHIAZIDE 234 189 26 9
METFORMIN HCL 232 191 27 12
LANTUS 226 184 28 49
TAMSULOSIN HCL 205 181 29 25
PANTOPRAZOLE SODIUM 199 156 30 36
OXYCONTIN 199 155 S2 30 87
LEVETIRACETAM 191 170 32 112
COMBIVENT 191 142 32 126
ISOSORBIDE MONONITRATE ER 187 186 34 70
RAMIPRIL 184 184 35 80
ALENDRONATE SODIUM 177 175 36 19
IPRATROPIUM-ALBUTEROL 177 170 36 96
TRAMADOL HCL 174 151 38 32
ADVAIR DISKUS 156 131 39 44
LOSARTAN POTASSIUM 156 156 39 15
METOPROLOL SUCCINATE 151 143 41 21
DIOVAN 147 142 42 26
PRAVASTATIN SODIUM 147 147 42 14
PROAIR HFA 141 98 44 38
EXELON 137 123 45 85
DIGOXIN 137 137 45 58
ESCITALOPRAM OXALATE 133 123 47 66
ENALAPRIL MALEATE 131 131 48 37
QUETIAPINE FUMARATE 131 122 48 61
GLIPIZIDE ER 129 113 50 69
LATANOPROST 128 128 51 120
FINASTERIDE 124 118 52 83
PREDNISONE 123 93 53 40
CLOPIDOGREL 117 96 54 42
SEROQUEL 116 105 55 107
CARVEDILOL 114 113 56 73
HYDRALAZINE HCL 109 104 57 122
CIPROFLOXACIN HCL 107 97 58 71
PLAVIX 107 95 58 74
CARBIDOPA-LEVODOPA 106 106 60 92
VENLAFAXINE HCL ER 106 95 60 86
ALLOPURINOL 105 92 62 28
FLUTICASONE PROPIONATE 104 100 63 34
NYSTATIN 103 87 64 125
FAMOTIDINE 103 91 64 115
PAROXETINE HCL 100 99 66 46
FENTANYL 99 82 S2 67 138
VANCOMYCIN HCL 97 48 68 192
SULFAMETHOXAZOLE-TRIMETHOPRIM 93 80 69 139
LIDOCAINE HCL 92 88 70 203
MELOXICAM 92 80 70 54
ZOLPIDEM TARTRATE 91 77 72 23
KLOR-CON M20 90 70 73 65
DILTIAZEM 24HR CD 86 86 74 104
LEXAPRO 82 57 75 169
LAMOTRIGINE 80 52 76 188
BACLOFEN 79 33 77 133
LACTULOSE 78 69 78 105
OLANZAPINE 76 64 79 108
ABILIFY 75 66 80 145
OXYCODONE-ACETAMINOPHEN 74 52 S2 81 84
COLCRYS 74 73 81 128
NEXIUM 74 53 81 56
TRILIPIX 71 62 84 186
FLUOXETINE HCL 71 55 84 57
MUPIROCIN 71 52 84 200
CEPHALEXIN 69 63 87 130
KETOCONAZOLE 67 41 88 196
LEVOFLOXACIN 66 61 89 93
AZITHROMYCIN 66 58 89 51
GLIPIZIDE 65 55 91 45
NYSTOP 65 54 91 140
METOCLOPRAMIDE HCL 64 49 93 185
SYNTHROID 63 43 94 41
AVELOX 63 57 94 184
CLOZAPINE 63 25 94 94
SYMBICORT 62 53 97 151
FENOFIBRATE 61 36 98 48
VERAPAMIL ER 60 51 99 77
RISPERIDONE 60 60 99 72
HUMALOG 59 47 101 153
BETHANECHOL CHLORIDE 59 44 101 247
NOVOLOG 58 35 103 106
VENTOLIN HFA 57 47 104 159
LIDOCAINE 57 57 104 225
JANUVIA 56 52 106 81
BISOPROLOL FUMARATE 56 46 106 67
OXYBUTYNIN CHLORIDE ER 54 51 108 124
ZETIA 53 30 109 89
ACTOS 53 26 109 175
AMOX TR-POTASSIUM CLAVULANATE 53 44 109 137
TRAVATAN Z 51 51 112 160
MORPHINE SULFATE 51 49 S2 112 268
DIVALPROEX SODIUM 51 50 112 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 14, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.